BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9710432)

  • 1. Retinoic acid uses divergent mechanisms to activate or suppress mitogenesis in rat aortic smooth muscle cells.
    Chen S; Gardner DG
    J Clin Invest; 1998 Aug; 102(4):653-62. PubMed ID: 9710432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular ATP and ADP stimulate proliferation of porcine aortic smooth muscle cells.
    Wang DJ; Huang NN; Heppel LA
    J Cell Physiol; 1992 Nov; 153(2):221-33. PubMed ID: 1358898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-trans retinoic acid inhibits vascular smooth muscle cell proliferation targeting multiple genes for cyclins and cyclin-dependent kinases.
    Kosaka C; Sasaguri T; Komiyama Y; Takahashi H
    Hypertens Res; 2001 Sep; 24(5):579-88. PubMed ID: 11675954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for p38 mitogen-activated protein kinase and c-myc in endothelin-dependent rat aortic smooth muscle cell proliferation.
    Chen S; Qiong Y; Gardner DG
    Hypertension; 2006 Feb; 47(2):252-8. PubMed ID: 16365184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators.
    Wakino S; Kintscher U; Kim S; Jackson S; Yin F; Nagpal S; Chandraratna RA; Hsueh WA; Law RE
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):746-51. PubMed ID: 11348869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
    Touyz RM; Yao G
    J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential utilization of cyclin D1 and cyclin D3 in the distinct mitogenic stimulations by growth factors and TSH of human thyrocytes in primary culture.
    Paternot S; Dumont JE; Roger PP
    Mol Endocrinol; 2006 Dec; 20(12):3279-92. PubMed ID: 16916940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvedilol inhibits vascular smooth muscle cell proliferation.
    Sung CP; Arleth AJ; Ohlstein EH
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):221-7. PubMed ID: 7679155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal.
    Ruef J; Rao GN; Li F; Bode C; Patterson C; Bhatnagar A; Runge MS
    Circulation; 1998 Mar; 97(11):1071-8. PubMed ID: 9531254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms.
    Weber H; Webb ML; Serafino R; Taylor DS; Moreland S; Norman J; Molloy CJ
    Mol Endocrinol; 1994 Feb; 8(2):148-58. PubMed ID: 8170471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-mediated vascular growth requires p42/p44 mitogen-activated protein kinase and p70 S6 kinase cascades via transactivation of epidermal growth factor receptor.
    Iwasaki H; Eguchi S; Ueno H; Marumo F; Hirata Y
    Endocrinology; 1999 Oct; 140(10):4659-68. PubMed ID: 10499523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades.
    Jones DA; Benjamin CW; Linseman DA
    Mol Pharmacol; 1995 Nov; 48(5):890-6. PubMed ID: 7476920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and progesterone inhibit vascular smooth muscle proliferation.
    Morey AK; Pedram A; Razandi M; Prins BA; Hu RM; Biesiada E; Levin ER
    Endocrinology; 1997 Aug; 138(8):3330-9. PubMed ID: 9231785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of lovastatin on proliferation of cultured rat mesangial and aortic smooth muscle cells.
    Choi KH; Kang SW; Lee SW; Lee HY; Han DS; Kang BS
    Yonsei Med J; 1995 Jul; 36(3):251-61. PubMed ID: 7660676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway.
    Won SM; Park YH; Kim HJ; Park KM; Lee WJ
    Exp Mol Med; 2006 Oct; 38(5):525-34. PubMed ID: 17079869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
    Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
    J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells.
    Yu SM; Chen SF; Lau YT; Yang CM; Chen JC
    Mol Pharmacol; 1996 Oct; 50(4):1000-9. PubMed ID: 8863847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha1-Adrenergic receptor stimulation of mitogenesis in human vascular smooth muscle cells: role of tyrosine protein kinases and calcium in activation of mitogen-activated protein kinase.
    Hu ZW; Shi XY; Lin RZ; Chen J; Hoffman BB
    J Pharmacol Exp Ther; 1999 Jul; 290(1):28-37. PubMed ID: 10381756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D-dependent suppression of endothelin-induced vascular smooth muscle cell proliferation through inhibition of CDK2 activity.
    Chen S; Law CS; Gardner DG
    J Steroid Biochem Mol Biol; 2010 Feb; 118(3):135-41. PubMed ID: 19961935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin inhibits thrombin-induced mitogen-activated protein kinase signaling in arterial smooth muscle cells.
    Hedin U; Daum G; Clowes AW
    J Vasc Surg; 1998 Mar; 27(3):512-20. PubMed ID: 9546238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.